Methotrexate and misoprostol for abortion.
D000019:Abortifacient Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D000020:Abortifacient Agents, Nonsteroidal / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D000028:Abortion, Induced; D000328:Adult; D005260:Female; D006801:Humans; D008727:Methotrexate / Q000009:adverse effects / Q000493:pharmacokinetics; D016595:Misoprostol / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D011247:Pregnancy; D011261:Pregnancy Trimester, First
D000019:Abortifacient Agents; D000020:Abortifacient Agents, Nonsteroidal; D016595:Misoprostol; D008727:Methotrexate